Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 1035 | 1252 | 782 | 1558 | - |
Fund Return | 6.54% | 3.5% | 25.16% | -7.86% | 9.27% | - |
Place in category | 423 | 276 | 463 | 447 | 279 | - |
% in Category | 79 | 48 | 88 | 88 | 61 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 21.58B | 9.64 | 8.41 | 8.07 | ||
Artisan International Value Advisor | 10.45B | 9.56 | 8.30 | - | ||
Artisan Mid Cap Institutional | 4.31B | 6.64 | -7.77 | 9.34 | ||
Artisan Mid Cap Investor | 4.2B | 6.44 | -7.99 | 9.08 | ||
Artisan International Small Cap Ins | 3.14B | 1.87 | -5.37 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.73B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 12.9B | 7.79 | 0.27 | - | ||
T. Rowe Price Mid-Cap Growth | 12.1B | 7.68 | 0.14 | 10.48 | ||
Vanguard Mid-Cap Growth Index Admir | 12.09B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price New Horizons I | 10.21B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 4.64 | 596.74 | +0.83% | |
Tyler Technologies | US9022521051 | 3.76 | 597.21 | -0.65% | |
Ascendis Pharma AS | US04351P1012 | 3.56 | 122.64 | -1.40% | |
Spotify Tech | LU1778762911 | 3.55 | 470.70 | +0.15% | |
West Pharmaceutical Services | US9553061055 | 3.32 | 320.88 | +2.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review